The New England Signal
Independent journalism covering all six New England states
New Hampshire

Shaheen, Collins lead letter from 243 lawmakers urging renewal of Special Diabetes Program

The co-chairs of the Senate Diabetes Caucus asked congressional leaders for a multi-year extension of the federal diabetes research and Native American care programs, whose authorization expires Dec. 31.

WASHINGTON — U.S. Sens. Jeanne Shaheen, D-N.H., and Susan Collins, R-Maine, are leading a bipartisan letter from 243 members of Congress urging Senate and House leaders in Washington to renew the Special Diabetes Program, Shaheen's office said Thursday.

According to the office, 56 other senators and 185 House members joined the letter, as did House Diabetes Caucus co-chairs Diana DeGette, D-Colo., and Gus Bilirakis, R-Fla. Shaheen and Collins co-chair the Senate Diabetes Caucus. New England senators who signed include Richard Blumenthal of Connecticut, Maggie Hassan of New Hampshire, Angus King of Maine, Ed Markey and Elizabeth Warren of Massachusetts, Jack Reed of Rhode Island and Peter Welch of Vermont.

The program has two parts, one funding Type 1 diabetes research and the Special Diabetes Program for Indians. Shaheen's office said she and Collins secured a short-term reauthorization at about $200 million a year in the fiscal 2026 funding packages, which the office called the highest level in the program's nearly 30-year history. Without further action by Congress, the program's authorization expires Dec. 31.

"Diabetes is one of our country's most expensive diseases in both human and economic terms," the lawmakers wrote. They cited a 2025 study that they said found research supported by the program had generated an estimated $50 billion in federal health care cost savings through improved diabetes management.

The letter said Congress has reauthorized the programs with bipartisan support regularly since they began in 1997, and that researchers and clinicians need "stable, predictable funding." The lawmakers asked leaders to support a multi-year extension.

Shaheen's office also said her bill to cap monthly out-of-pocket insulin costs at $35, the INSULIN Act, is closer than ever to passing the Senate after advancing out of the Senate Health, Education, Labor and Pensions Committee.

This brief was drafted by AI from a public agency or political press release and published by The New England Signal. Why we use AI for stories like this one.

New Hampshire
Add The New England Signal as a preferred source on Google